Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366462721> ?p ?o ?g. }
- W4366462721 endingPage "e1010870" @default.
- W4366462721 startingPage "e1010870" @default.
- W4366462721 abstract "The SARS-CoV-2 non-Spike (S) structural protein targets on nucleocapsid (N), membrane (M) and envelope (E), critical in the host cell interferon response and memory T-cell immunity, are grossly overlooked in COVID vaccine development. The current Spike-only vaccines bear an intrinsic shortfall for promotion of a fuller T cell immunity. Vaccines designed to target conserved epitopes could elicit strong cellular immune responses that would synergize with B cell responses and lead to long-term vaccine success. We pursue a universal (pan-SARS-CoV-2) vaccine against Delta, Omicrons and ever-emergent new mutants.We explored booster immunogenicity of UB-612, a multitope-vaccine that contains S1-RBD-sFc protein and sequence-conserved promiscuous Th and CTL epitope peptides on the Sarbecovirus N, M and S2 proteins. To a subpopulation (N = 1,478) of infection-free participants (aged 18-85 years) involved in a two-dose Phase-2 trial, a UB-612 booster (third dose) was administered 6-8 months after the second dose. The immunogenicity was evaluated at 14 days post-booster with overall safety monitored until the end of study. The booster induced high viral-neutralizing antibodies against live Wuhan WT (VNT50, 1,711) and Delta (VNT50, 1,282); and against pseudovirus WT (pVNT50, 11,167) vs. Omicron BA.1/BA.2/BA.5 variants (pVNT50, 2,314/1,890/854), respectively. The lower primary neutralizing antibodies in the elderly were uplifted upon boosting to approximately the same high level in young adults. UB-612 also induced potent, durable Th1-oriented (IFN-γ+-) responses (peak/pre-boost/post-boost SFU/106 PBMCs, 374/261/444) along with robust presence of cytotoxic CD8+ T cells (peak/pre-boost/post-boost CD107a+-Granzyme B+, 3.6%/1.8%/1.8%). This UB-612 booster vaccination is safe and well tolerated without SAEs.By targeting conserved epitopes on viral S2, M and N proteins, UB-612 could provide potent, broad and long-lasting B-cell and T-cell memory immunity and offers the potential as a universal vaccine to fend off Omicrons and new VoCs without resorting to Omicron-specific immunogens.ClinicalTrials.gov ID: NCT04773067; ClinicalTrials.gov ID: NCT05293665; ClinicalTrials.gov ID: NCT05541861." @default.
- W4366462721 created "2023-04-22" @default.
- W4366462721 creator A5001036414 @default.
- W4366462721 creator A5024561819 @default.
- W4366462721 creator A5032623175 @default.
- W4366462721 creator A5034441934 @default.
- W4366462721 creator A5035253994 @default.
- W4366462721 creator A5046131128 @default.
- W4366462721 creator A5074866951 @default.
- W4366462721 creator A5085426512 @default.
- W4366462721 creator A5089833613 @default.
- W4366462721 date "2023-04-20" @default.
- W4366462721 modified "2023-09-30" @default.
- W4366462721 title "Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses" @default.
- W4366462721 cites W2004583429 @default.
- W4366462721 cites W3081417452 @default.
- W4366462721 cites W3082438395 @default.
- W4366462721 cites W3083285583 @default.
- W4366462721 cites W3132096252 @default.
- W4366462721 cites W3163785571 @default.
- W4366462721 cites W3164926277 @default.
- W4366462721 cites W3175972973 @default.
- W4366462721 cites W3185122688 @default.
- W4366462721 cites W3193191879 @default.
- W4366462721 cites W3196516725 @default.
- W4366462721 cites W3199695188 @default.
- W4366462721 cites W3200259362 @default.
- W4366462721 cites W3212533337 @default.
- W4366462721 cites W3215049942 @default.
- W4366462721 cites W4200033584 @default.
- W4366462721 cites W4200210635 @default.
- W4366462721 cites W4200230275 @default.
- W4366462721 cites W4200274151 @default.
- W4366462721 cites W4200502159 @default.
- W4366462721 cites W4205170398 @default.
- W4366462721 cites W4205218806 @default.
- W4366462721 cites W4205283268 @default.
- W4366462721 cites W4205813835 @default.
- W4366462721 cites W4206135665 @default.
- W4366462721 cites W4206153788 @default.
- W4366462721 cites W4206902820 @default.
- W4366462721 cites W4206997616 @default.
- W4366462721 cites W4210242202 @default.
- W4366462721 cites W4210308999 @default.
- W4366462721 cites W4210792795 @default.
- W4366462721 cites W4213304618 @default.
- W4366462721 cites W4220689791 @default.
- W4366462721 cites W4220988150 @default.
- W4366462721 cites W4221072241 @default.
- W4366462721 cites W4224233017 @default.
- W4366462721 cites W4224300962 @default.
- W4366462721 cites W4224438969 @default.
- W4366462721 cites W4225011156 @default.
- W4366462721 cites W4225266546 @default.
- W4366462721 cites W4225386205 @default.
- W4366462721 cites W4225470021 @default.
- W4366462721 cites W4225691034 @default.
- W4366462721 cites W4226059255 @default.
- W4366462721 cites W4226102343 @default.
- W4366462721 cites W4226229183 @default.
- W4366462721 cites W4226341907 @default.
- W4366462721 cites W4226343533 @default.
- W4366462721 cites W4226391586 @default.
- W4366462721 cites W4226491433 @default.
- W4366462721 cites W4229442811 @default.
- W4366462721 cites W4229458272 @default.
- W4366462721 cites W4280504222 @default.
- W4366462721 cites W4280594901 @default.
- W4366462721 cites W4281476185 @default.
- W4366462721 cites W4281754639 @default.
- W4366462721 cites W4282566752 @default.
- W4366462721 cites W4282980823 @default.
- W4366462721 cites W4283026725 @default.
- W4366462721 cites W4283157316 @default.
- W4366462721 cites W4283165975 @default.
- W4366462721 cites W4283171904 @default.
- W4366462721 cites W4283319609 @default.
- W4366462721 cites W4283704819 @default.
- W4366462721 cites W4284886202 @default.
- W4366462721 cites W4285993171 @default.
- W4366462721 cites W4286219778 @default.
- W4366462721 cites W4286220782 @default.
- W4366462721 cites W4291020805 @default.
- W4366462721 cites W4292229998 @default.
- W4366462721 cites W4294606672 @default.
- W4366462721 cites W4295777530 @default.
- W4366462721 cites W4296026861 @default.
- W4366462721 cites W4308767470 @default.
- W4366462721 cites W4315631193 @default.
- W4366462721 cites W4315632027 @default.
- W4366462721 cites W4317666420 @default.
- W4366462721 doi "https://doi.org/10.1371/journal.ppat.1010870" @default.
- W4366462721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37079651" @default.
- W4366462721 hasPublicationYear "2023" @default.
- W4366462721 type Work @default.
- W4366462721 citedByCount "3" @default.
- W4366462721 countsByYear W43664627212023 @default.
- W4366462721 crossrefType "journal-article" @default.